"Understanding the Impact of COVID Variant JN.1 and Latest Treatment Studies"

The JN.1 variant is now the most prevalent COVID-19 variant globally, responsible for over 60% of new cases in the U.S., and is associated with an increase in COVID-19 deaths and hospital admissions. It carries about 30 mutations, making it adept at evading immunity and transmitting more efficiently. Symptoms are similar to other COVID-19 strains, with emerging data suggesting it may cause more diarrhea. The CDC indicates that the continued growth of JN.1 suggests it is either more transmissible or better at evading immune systems, and updated COVID-19 vaccines are expected to increase protection against it.